Abbott India (NSE:ABBOTINDIA) E10: ₹480.56 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ABBOTINDIA Abbott India Ltd NSE:ABBOTINDIA
87 GF Score
Price ₹26,905.00
GF Value ₹32,322.24
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Abbott India E10?

Abbott India NSE:ABBOTINDIA -0.57% 87 E10 is ₹480.56 as of Jun. 2026. GuruFocus rates NSE:ABBOTINDIA with a GF Score™ of 87/100 and a GF Value™ of ₹32,322.24 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Abbott India's adjusted earnings per share data for the three months ended in Jun. 2026 was ₹201.660. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹480.56 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Abbott India's average E10 Growth Rate was 18.20% per year. During the past 3 years, the average E10 Growth Rate was 18.90% per year. During the past 5 years, the average E10 Growth Rate was 18.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Abbott India was 19.70% per year. The lowest was 16.90% per year. And the median was 18.80% per year.

As of today (2026-08-18), Abbott India's current stock price is ₹26905.00. Abbott India's E10 for the quarter that ended in Jun. 2026 was ₹480.56. Abbott India's Shiller PE Ratio of today is 55.99.

During the past 13 years, the highest Shiller PE Ratio of Abbott India was 105.10. The lowest was 54.17. And the median was 80.11.


Abbott India  (NSE:ABBOTINDIA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Abbott India's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=26905.00/480.56
=55.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Abbott India was 105.10. The lowest was 54.17. And the median was 80.11.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Abbott India E10 Related Terms


Abbott India E10 Historical Data

* Premium members only.

The historical data trend for Abbott India's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott India E10 Chart

Abbott India Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 225.48 271.89 329.73 386.12 457.11

Abbott India Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 404.18 425.30 439.76 457.11 480.56

NSE:ABBOTINDIA vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Abbott India's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Abbott India's Shiller PE Ratio falls into.


NSE:ABBOTINDIA
87GF Score
Abbott India Ltd NSE:ABBOTINDIA
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott India E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abbott India's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=201.66/167.3573*167.3573
=201.660

Current CPI (Jun. 2026) = 167.3573.

Abbott India Quarterly Data

per share eps CPI Adj_EPS
201609 35.300 105.961 55.754
201612 40.260 105.196 64.050
201703 19.790 105.196 31.484
201706 22.710 107.109 35.484
201709 64.720 109.021 99.351
201712 54.300 109.404 83.064
201803 47.100 109.786 71.799
201806 38.780 111.317 58.303
201809 64.790 115.142 94.171
201812 55.080 115.142 80.058
201903 53.280 118.202 75.437
201906 55.030 120.880 76.189
201909 83.920 123.175 114.022
201912 87.850 126.235 116.468
202003 52.240 124.705 70.107
202006 84.870 127.000 111.839
202009 85.050 130.118 109.391
202012 83.360 130.889 106.586
202103 71.760 131.771 91.140
202106 92.120 134.084 114.980
202109 90.510 135.847 111.504
202112 93.740 138.161 113.549
202203 99.490 138.822 119.941
202206 96.770 142.347 113.772
202209 124.950 144.661 144.554
202212 116.160 145.763 133.369
202303 108.900 146.865 124.095
202306 136.580 150.280 152.100
202309 147.270 151.492 162.693
202312 146.340 152.924 160.152
202403 135.090 153.035 147.733
202406 154.360 155.789 165.822
202409 168.760 157.882 178.888
202412 169.780 158.323 179.468
202503 172.720 157.552 183.470
202506 172.170 159.755 180.363
202509 195.420 162.289 201.523
202512 176.920 163.281 181.337
202603 185.850 164.272 189.340
202606 201.660 167.357 201.660

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹480.56 mean?
Abbott India (NSE:ABBOTINDIA) has a E10 of ₹480.56 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Abbott India and its competitors.
Is Abbott India's E10 too high?
Abbott India's current E10 is ₹480.56. Overall, Abbott India has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott India's E10 compare to ZTS?
Abbott India's E10 of ₹480.56 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Abbott India and its competitors. Abbott India's current E10 is ₹480.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott India stock overvalued right now?
Based on GuruFocus' analysis, Abbott India (NSE:ABBOTINDIA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹32,322.24, compared to a current price of ₹26,905.00 — trading 16.8% below its estimated fair value. The current E10 is ₹480.56. Abbott India's overall GF Score™ is 87/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Abbott India (NSE:ABBOTINDIA), the current E10 is ₹480.56 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott India (NSE:ABBOTINDIA) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott India stock appears to be undervalued. The current stock price of ₹26,905.00 is trading 16.8% below its estimated GF Value™ of ₹32,322.24. GuruFocus considers Abbott India to be Modestly Undervalued.

Key valuation signals for NSE:ABBOTINDIA:

  • E10: ₹480.56
  • GF Value™: ₹32,322.24 vs. price of ₹26,905.00 (16.8% below fair value)
  • GF Score™: 87/100 with 1 warning sign

No single metric tells the full story. See the NSE:ABBOTINDIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abbott India Business Description

Other Exchanges 500488:India
Address Plot C-68, G Block, 16th Floor, Godrej BKC, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400051
Abbott India Ltd is a drug manufacturing company that offers products in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. Its patient focus centers overwhelmingly on women's health and gastrointestine, gastroenterology, and hepatic care. Geographically, the majority of the company's revenue is generated in India.
87GF Score

Get the complete analysis for NSE:ABBOTINDIA

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹26,905.00
Price
₹32,322.24
GF Value